Clinical Trials Browser

Phase 1/2 × envafolimab × Sarcoma × Clear all

NCT05448820 2023-09-21

YH001 Plus Envafolimab With or Without Doxorubicin in Patients With Advanced or Metastatic Sarcoma

Phase 1/2 Unknown

Diabetes Mellitus, Insulin-Dependent, 12, Chondrosarcoma, Sarcoma